Neogen
NEOG
10.55
-0.30
-2.77%
Neogen
US · NEOG
#2579 by market cap
Listed 1970
10.55
-0.30
-2.77%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $13Market Newswire · 2026/8/3
-
Company notice
Neogen | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ranalli Tamara A.SEC · 2026/1/29
-
Neogen Q1 Adj. EPS $0.08 Beats $(0.07) Estimate, Sales $222.800M Beat $208.175M EstimateBenzinga · 2026/10/7
-
Rating change
Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $12Market Newswire · 2026/1/9
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)TipRanks · 2026/9/28
-
Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2026/10/7
-
Company notice
Neogen | 3: Initial statement of beneficial ownership of securities-Officer Ranalli Tamara A.SEC · 2026/1/26
-
Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $14Market Newswire · 2026/9/30
-
Rating change
Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)TipRanks · 2026/7/30
-
Rating change
Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2026/7/31
-
Rating change
Piper Sandler Upgrades Neogen(NEOG.US) to Buy Rating, Raises Target Price to $14Market Newswire · 2026/8/26
-
Company notice
Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.SEC · 2025/12/3
-
Rating change
CJS Securities Upgrades Neogen(NEOG.US) to Buy Rating, Maintains Target Price $10Market Newswire · 2025/12/10
-
Company notice
Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.SEC · 2025/10/29
-
Rating change
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $6.5Market Newswire · 2025/10/16
-
William Blair Maintains Neogen(NEOG.US) With Hold RatingMarket Newswire · 2026/9/28
-
Company notice
Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Ranalli Tamara A.SEC · 2026/1/26
-
Rating change
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $10Market Newswire · 2026/1/13
-
Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2026/10/20
-
Rating change
Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Cuts Target Price to $8Market Newswire · 2025/10/10
-
Rating change
CJS Securities Initiates Neogen(NEOG.US) With Hold Rating, Announces Target Price $10Market Newswire · 2025/9/29
-
Rating change
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Maintains Target Price $5Market Newswire · 2025/8/4
-
Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2026/9/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Neogen discussion 0 comments